1.Bhakta N Liu Q Ness KK et al.

The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).

Lancet. 390: 2569-25822.

Survivors of childhood and adolescent cancer: life-long risks and responsibilities.

Nat Rev Cancer. 14: 61-703.Pui CH Yang JJ Hunger SP et al.

Childhood acute lymphoblastic leukemia: progress through collaboration.

J Clin Oncol. 33: 2938-29484.Toft N Birgens H Abrahamsson J et al.

Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia.

Leukemia. 32: 606-6155.Armstrong GT Chen Y Yasui Y et al.

Reduction in late mortality among 5-year survivors of childhood cancer.

N Engl J Med. 374: 833-8426.Gibson TM Mostoufi-Moab S Stratton KL et al.

Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970–99: a report from the Childhood Cancer Survivor Study cohort.

Lancet Oncol. 19: 1590-16017.US Department of Health and Human ServicesNational Institutes of HealthNational Cancer Institute

Common Terminology Criteria for Adverse Events (CTCAE) version 5.0.

8.Schmiegelow K Attarbaschi A Barzilai S et al.

Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus.

Lancet Oncol. 17: e231-e2399.Pui CH Schrappe M Masera G et al.

Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop.

Leukemia. 18: 1043-105310.Hudson MM Ehrhardt MJ Bhakta N et al.

Approach for classification and severity grading of long-term and late-onset health events among childhood cancer survivors in the St Jude lifetime cohort.

Cancer Epidemiol Biomarkers Prev. 26: 666-67411.

The Delphi technique: making sense of consensus.

Pract Assess, Res Eval. 12: 1-812.Diamond IR Grant RC Feldman BM et al.

Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies.

J Clin Epidemiol. 67: 401-40913.Clemens E van den Heuvel-Eibrink MM Mulder RL et al.

Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.

Lancet Oncol. 20: e29-e4114.

Auditory and ophthalmological findings in children with acute lymphoblastic leukemia.

Pediatr Hematol Oncol. 9: 255-25915.Harada T Namiki S Kawabata I

Acute profound sensorineural hearing loss as the initial manifestation of acute leukemia—report of a case.

Auris Nasus Larynx. 27: 359-36216.Terao K Cureoglu S Schachern PA et al.

Pathologic correlations of otologic symptoms in acute lymphocytic leukemia.

Am J Otolaryngol. 32: 13-1817.

Ototoxic effects and mechanisms of loop diuretics.

J Otol. 11: 145-15618.

Cochlear implant.

Otolaryngol Clin North Am. 53: 87-10219.Whelan KF Stratton K Kawashima T et al.

Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study.

Pediatr Blood Cancer. 54: 103-10920.Freycon F Casagranda L Trombert-Paviot B

The impact of severe late-effects after 12 Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988–2010).

Pediatr Hematol Oncol. 36: 86-10221.Alloin AL Barlogis V Auquier P et al.

Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study.

Br J Haematol. 164: 94-10022.Armenian SH Armstrong GT Aune G et al.

Cardiovascular disease in survivors of childhood cancer: Insights into epidemiology, pathophysiology, and prevention.

J Clin Oncol. 36: 2135-214423.Chow EJ Leger KJ Bhatt NS et al.

Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.

Cardiovasc Res. 115: 922-93424.

Two cases of aspergillus endocarditis in non neutropenic children on chemotherapy for acute lymphoblastic leukaemia.

Hematol Rep. 3: e725.Mulrooney DA Hyun G Ness KK et al.

Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort.

BMJ. 368l679426.Hau EM Caccia JN Kasteler R et al.

Cardiovascular disease after childhood acute lymphoblastic leukaemia: a cohort study.

Swiss Med Wkly. 149w2001227.

Pediatric heart transplantation-indications and outcomes in the current era.

J Thorac Dis. 6: 1080-109628.Wilhelm BJ Thöne M El-Scheich T Livert D Angelico R Osswald B

Complications and risk assessment of 25 years in pediatric pacing.

Ann Thorac Surg. 100: 147-15329.Emery RW Krogh CC Arom KV et al.

The St Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement.

Ann Thorac Surg. 79 (): 776-78230.Caldarone CA Raghuveer G Hills CB et al.

Long-term survival after mitral valve replacement in children aged <5 years: a multi-institutional study.

Circulation. 104: I143-I14731.Lipshultz SE Lipsitz SR Sallan SE et al.

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.

J Clin Oncol. 23: 2629-263632.Lipshultz SE Colan SD Gelber RD Perez-Atayde AR Sallan SE Sanders SP

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.

N Engl J Med. 324: 808-81533.Shafey A Ethier MC Traubici J Naqvi A Sung L

Incidence, risk factors, and outcomes of enteritis, typhlitis, and colitis in children with acute leukemia.

J Pediatr Hematol Oncol. 35: 514-51734.Toksvang LN Schmidt MS Arup S et al.

Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: a systematic review.

PLoS One. 14e021215735.De Bruyne R Portmann B Samyn M et al.

Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia.

J Hepatol. 44: 407-41036.Wolthers BO Frandsen TL Abrahamsson J et al.

Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol.

Leukemia. 31: 325-33237.Wolthers BO Frandsen TL Baruchel A et al.

Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study.

Lancet Oncol. 18: 1238-124838.Rawshani A Rawshani A Franzén S et al.

Mortality and cardiovascular disease in type 1 and type 2 diabetes.

N Engl J Med. 376: 1407-141839.Patterson CC Dahlquist GG Gyürüs E Green A Soltész G

Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study.

Lancet. 373: 2027-203340.

Incidence and trends of childhood type 1 diabetes worldwide 1990–1999.

Diabet Med. 23: 857-86641.Dabelea D Mayer-Davis EJ Saydah S et al.

Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.

JAMA. 311: 1778-178642.Kooijmans ECM Bökenkamp A Tjahjadi NS et al.

Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Cochrane Database Syst Rev. 3CD00894443.Fidler MM Reulen RC Bright CJ et al.

Respiratory mortality of childhood, adolescent and young adult cancer survivors.

Thorax. 73: 959-96844.Suh E Stratton KL Leisenring WM et al.

Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study.

Lancet Oncol. 21: 421-43545.te Winkel ML Pieters R Hop WCJ et al.

Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.

J Clin Oncol. 29: 4143-415046.Mattano Jr, LALA Sather HN Trigg ME Nachman JB

Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.

J Clin Oncol. 18: 3262-327247.Mogensen SS Harila-Saari A Mäkitie O et al.

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.

Pediatr Blood Cancer. 65e2730048.Kinahan KE Sharp LK Seidel K et al.

Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor study.

J Clin Oncol. 30: 2466-247449.Chosidow O Bagot M Vernant JP et al.

Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases.

J Am Acad Dermatol. 26: 49-5550.Parasole R Petruzziello F Menna G et al.

Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.

Leuk Lymphoma. 51: 1063-107151.Banerjee J Niinimäki R Lähteenmäki P et al.

The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia.

Pediatr Blood Cancer. 67e2799952.Millan NC Pastrana A Guitter MR Zubizarreta PA Monges MS Felice MS

Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia.

Leuk Res. 65: 86-9353.Ochs JJ Bowman WP Pui CH Abromowitch M Mason C Simone JV

Seizures in childhood lymphoblastic leukaemia patients.

Lancet. 2: 1422-142454.Khan RB Morris EB Pui CH et al.

Long-term outcome and risk factors for uncontrolled seizures after a first seizure in children with hematological malignancies.

J Child Neurol. 29: 774-78155.

Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: a systematic review.

Neurosci Biobehav Rev. 53: 108-12056.Jacola LM Krull KR Pui CH et al.

Longitudinal assessment of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia treated on a contemporary chemotherapy protocol.

J Clin Oncol. 34: 1239-124757.Krull KR Brinkman TM Li C et al.

Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.

J Clin Oncol. 31: 4407-441558.Judd LL Schettler PJ Brown ES et al.

Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects.

Am J Psychiatry. 171: 1045-105159.Liu W Cheung YT Brinkman TM et al.

Behavioral symptoms and psychiatric disorders in child and adolescent long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.

Psychooncology. 27: 1597-160760.Goldsby RE Liu Q Nathan PC et al.

Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.

J Clin Oncol. 28: 324-33161.

Cancer therapy-induced residual bone marrow injury-Mechanisms of induction and implication for therapy.

Curr Cancer Ther Rev. 2: 271-27962.Kosmidis S Baka M Bouhoutsou D et al.

Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL.

Pediatr Blood Cancer. 50: 528-53263.Hijiya N Hudson MM Lensing S et al.

Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.

JAMA. 297: 1207-121564.Bhatia S Sather HN Pabustan OB Trigg ME Gaynon PS Robison LL

Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.

Blood. 99: 4257-426465.Schmiegelow K Levinsen MF Attarbaschi A et al.

Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.

J Clin Oncol. 31: 2469-247666.

The ROC curve redefined—optimising sensitivity (and specificity) to the lived reality of cancer.

N Engl J Med. 380: 1594-159567.

Perspective: is childhood cancer a chronic disease?.

J Pediatr Hematol Oncol. 29: 595-59768.Izraeli S Vora A Zwaan CM Whitlock J

How I treat ALL in Down's syndrome: pathobiology and management.

Blood. 123: 35-4069.Rank CU Wolthers BO Grell K et al.

Asparaginase-associated pancreatitis in acute lymphoblastic leukemia: Results from the NOPHO ALL2008 treatment of patients 1–45 years of age.

J Clin Oncol. 38: 145-15470.Vetsch J Wakefield CE Robertson EG et al.

Health-related quality of life of survivors of childhood acute lymphoblastic leukemia: a systematic review.

Qual Life Res. 27: 1431-144371.Andrés-Jensen L Larsen HB Johansen C Frandsen TL Schmiegelow K Wahlberg A

Everyday life challenges among adolescent and young adult survivors of childhood acute lymphoblastic leukemia: an in-depth qualitative study.

Psychooncology. 29: 1630-163772.Thanarajasingam G Minasian LM Baron F et al.

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.

Lancet Haematol. 5: e563-e59873.Dong H Robison LL Leisenring WM Martin LJ Armstrong GT Yasui Y

Estimating the burden of recurrent events in the presence of competing risks: the method of mean cumulative count.

Am J Epidemiol. 181: 532-54074.

Pharmacogenomics and ALL treatment: how to optimize therapy.

Semin Hematol. 57: 130-13675.

Acute lymphoblastic leukaemia in children with Down syndrome: an updated review.

Br J Haematol. 155: 420-425